Page last updated: 2024-12-06

zingerone

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Zingerone is a natural compound found in ginger, responsible for its pungent and spicy flavor. It is a phenolic compound with a methoxy group and a ketone group attached to a benzene ring. Zingerone can be synthesized through various methods, including the condensation of vanillin with acetone. Research on zingerone is driven by its potential therapeutic effects, such as anti-inflammatory, analgesic, antioxidant, and anti-cancer activities. Its ability to modulate various signaling pathways, including those involved in inflammation and pain, makes it a promising candidate for developing new drugs. Zingerone's biological activity is also attributed to its ability to scavenge free radicals and protect cells from oxidative stress. Studies on zingerone focus on understanding its mechanisms of action, exploring its therapeutic potential, and developing novel formulations for its delivery.'

zingerone: pungent principle of ginger; structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

zingerone : A methyl ketone that is 4-phenylbutan-2-one in which the phenyl ring is substituted at positions 3 and 4 by methoxy and hydroxy groups respectively. The major pungent component in ginger. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID31211
CHEMBL ID25894
CHEBI ID68657
SCHEMBL ID119051
MeSH IDM0061733

Synonyms (82)

Synonym
vanillyl acetone
2-(4-hydroxy-3-methoxyphenyl)ethyl methyl ketone
einecs 204-548-3
hsdb 1064
3-methoxy-4-hydroxy-benzylacetone
ai3-31837
fema no. 3124
4-(4-hydroxy-3-methoxyphenyl)-2-butanone
(0)-paradol
brn 2051099
zingherone
ccris 2036
nsc 15335
4-(3-methoxy-4-hydroxyphenyl)-2-butanone
gingerone
4(4-hydroxy-3-methoxyphenyl)-2-butanone
nsc-15335
2-butanone, 4-(4-hydroxy-3-methoxyphenyl)-
zingerone
[0]-paradol
122-48-5
4-hydroxy-3-methoxybenzylacetone
zingiberone
3-methoxy-4-hydroxybenzylacetone
(4-hydroxy-3-methoxyphenyl)ethyl methyl ketone
nsc15335
vanillylacetone ,
4-(4-hydroxy-3-methoxy-phenyl)-butan-2-one
inchi=1/c11h14o3/c1-8(12)3-4-9-5-6-10(13)11(7-9)14-2/h5-7,13h,3-4h2,1-2h
4-(4-hydroxy-3-methoxyphenyl)butan-2-one
vanillylacetone, >=96%, fg
CHEMBL25894 ,
chebi:68657 ,
C17497
bdbm50304073
4mmw850892 ,
unii-4mmw850892
4-08-00-01866 (beilstein handbook reference)
(o)-paradol
cas-122-48-5
tox21_302493
NCGC00256663-01
dtxsid8047420 ,
dtxcid6027420
H1314
AKOS009462778
FT-0616634
vanillylaceton [who-dd]
vanillylaceton
zingerone [fhfi]
zingerone [fcc]
zingerone [inci]
zingerone [mi]
zingerone [hsdb]
4-(3-methoxy-4-hydroxyphenyl)butan-2-one
S2371
CCG-208511
SCHEMBL119051
AC-34331
vanillylacetone, >=98%, natural, fg
W-108429
CS-0003480
vanillylacetone;gingerone
zingerone, analytical reference material
mfcd00048232
HMS3651E22
sr-05000013705
SR-05000013705-1
AS-65368
4-(4-hydroxy-3-methoxyphenyl)-2-butanone, 9ci, 8ci
[0]paradol
fema 3124
SY017980
SW219618-1
HY-14621
DB15589
Q1064625
STL564783
A891122
EN300-1721864
Z1255442373
4-(4-hydroxy-3-methoxyphenyl)-

Research Excerpts

Overview

Zingerone is a non-volatile compound found mainly in dried ginger. Zingerone (Z) is a phenolic alkanone derived from natural sources with anti-inflammatory and antioxidant effects.

ExcerptReferenceRelevance
"Zingerone is a non-volatile compound found mainly in dried ginger. "( Zingerone stimulates osteoblast differentiation by increasing Smad1/5/9-mediated HO-1 expression in MC3T3-E1 cells and primary mouse calvarial cells.
Jang, WG; Kim, AR; Lim, YJ, 2022
)
3.61
"Zingerone is a component of ginger with multiple pharmacological activities."( The protective role of exogenous Ghrelin versus its combination with Zingerone on experimentally induced gastric ischemic-reperfusion in adult male albino rats.
Samy, W, 2022
)
1.68
"Zingerone is a flavor phytochemical present in ginger, a flowering plant belonging to the Zingiberaceae family used as a condiment and herbal remedy. "( Promising influences of zingerone against natural and chemical toxins: A comprehensive and mechanistic review.
Ajiboye, BO; Askari, VR; Baradaran Rahimi, V; Ghasemi, J; Mahzoon, E; Nazer, Y; Shamsabadi, S, 2023
)
2.66
"Zingerone (Z) is a phenolic alkanone derived from natural sources with anti-inflammatory and antioxidant effects. "( A Zingerone Analog, Acetyl Zingerone, Bolsters Matrisome Synthesis, Inhibits Matrix Metallopeptidases, and Represses IL-17A Target Gene Expression.
Bojanowski, K; Chaudhuri, RK; Swindell, WR, 2020
)
2.72
"Zingerone (ZO) is an ingredient of ginger (Zingiber officinale) which has different pharmacological properties. "( Modulatory effect of zingerone against cisplatin or γ-irradiation induced hepatotoxicity by molecular targeting regulation.
Badawy, MMM; Mohamed, HE, 2019
)
2.28
"Zingerone (ZN) is a phenylbutanoid recently found that structurally resembles ME and RK, both of which are phytochemicals commonly used as male attractants in fruit fly control programmes."( Zingerone improves mating performance of Zeugodacus tau (Diptera: Tephritidae) through enhancement of male courtship activity and sexual signaling.
Shamshir, RA; Wee, SL,
)
2.3
"Zingerone is a natural product with radioprotective effects."( Protective effects of zingerone derivate on ionizing radiation-induced intestinal injury.
Cui, J; Dong, Y; Duan, Y; Fan, S; Li, D; Li, H; Li, Y; Wang, M; Wu, J, 2019
)
1.55
"Zingerone is a strong anti-oxidant, with very less side effects and has exceptional property of scavenging free radicals, hence reducing the oxidative stresses."( Zingerone prevents lead-induced toxicity in liver and kidney tissues by regulating the oxidative damage in Wistar rats.
Ahmad, P; Ahmad, SB; Amin, I; Arafah, A; Ganaie, SA; Hussain, I; Mir, BA; Mir, MUR; Muzamil, S; Rehman, MU; Shanaz, S, 2021
)
2.79
"Zingerone is a pharmacologically active component of dry ginger."( Protective effects of zingerone on high cholesterol diet-induced atherosclerosis through lipid regulatory signaling pathway.
Geng, X; Liu, H; Sun, J; Wang, J; Yuwen, Q; Zhang, S; Zhang, X, 2021
)
1.66
"Zingerone is a stable active component derived from dry ginger rhizome."( Zingerone attenuates diabetic nephropathy through inhibition of nicotinamide adenine dinucleotide phosphate oxidase 4.
Bao, Y; Cui, Y; Hua, Q; Liu, Y; Shi, Y; Wang, S, 2018
)
2.64
"Zingerone is a likely active constituent responsible for the antidiarrheal activity of ginger."( Inhibitory effects of zingerone, a pungent component of Zingiber officinale Roscoe, on colonic motility in rats.
Hirayama, H; Iwami, M; Shiina, T; Shima, T; Shimizu, Y; Takewaki, T, 2011
)
1.41

Effects

Zingerone (ZO) has been proven to be effective for many diseases. Zingerone has been shown to have a wide range of pharmacological properties, including scavenging free radicals and suppressing lipid peroxidation.

ExcerptReferenceRelevance
"Zingerone (ZO) has been proven to be effective for many diseases."( Short-term treatment with zingerone ameliorates dextran sulfate sodium-induced mouse experimental colitis.
Cui, Y; Huang, J; Liu, S; Liu, Y; Zhang, Z; Zhou, Y; Zhu, Z, 2022
)
1.74
"Zingerone has emerged as a unique male fruit fly lure that can attract dacine fruit flies that are weakly or non-responsive to methyl eugenol and cuelure."( Systematic Modification of Zingerone Reveals Structural Requirements for Attraction of Jarvis's Fruit Fly.
Hanssen, BL; Jamie, IM; Jamie, JF; Park, SJ; Royer, JE; Taylor, PW, 2019
)
1.53
"Zingerone has been shown to have a wide range of pharmacological properties, including scavenging free radicals, high antioxidant activity, suppressing lipid peroxidation and anti-inflammatory."( Protective effects of zingerone on high cholesterol diet-induced atherosclerosis through lipid regulatory signaling pathway.
Geng, X; Liu, H; Sun, J; Wang, J; Yuwen, Q; Zhang, S; Zhang, X, 2021
)
1.66
"Zingerone has proved to be one such agent which can be employed as a potential anti-virulent drug candidate against P."( Structural alterations in Pseudomonas aeruginosa by zingerone contribute to enhanced susceptibility to antibiotics, serum and phagocytes.
Chhibber, S; Harjai, K; Kumar, L, 2014
)
1.37
"Zingerone has potent anti-inflammatory, antidiabetic, antilipolytic, antidiarrhoeic, antispasmodic, and so forth properties."( A Review on Pharmacological Properties of Zingerone (4-(4-Hydroxy-3-methoxyphenyl)-2-butanone).
Afzal, I; Ahmad, B; Amin, I; Arif, A; Bhat, SA; Bilal, S; Hussain, I; Mir, Mu; Rasool, S; Rehman, MU, 2015
)
1.4

Actions

ExcerptReferenceRelevance
"The zingerone-induced increase in HO-1 luciferase activity was suppressed by PP2A Cα."( Zingerone stimulates osteoblast differentiation by increasing Smad1/5/9-mediated HO-1 expression in MC3T3-E1 cells and primary mouse calvarial cells.
Jang, WG; Kim, AR; Lim, YJ, 2022
)
2.64

Treatment

Zingerone treatment prevented coronary thrombosis in isoproterenol induced myocardial infarcted rats. Zingerone attenuated the gain in final body weights, preserved liver structure, and downregulated the transcription of Bax and cleaved caspase-3. The treatment with zingerone markedly abrogated ROS levels, inhibited the NF-B activation and considerably reduced level of other downstream inflammatory molecules.

ExcerptReferenceRelevance
"Zingerone pretreatment revealed significant (P<0.05) preventive effects on all the above mentioned biochemical and molecular parameters evaluated in myocardial infarcted rats."( A molecular mechanism on the antiapoptotic effects of zingerone in isoproterenol induced myocardial infarcted rats.
Hemalatha, KL; Stanely Mainzen Prince, P, 2018
)
1.45
"Zingerone pre-treatment significantly reduced the abnormalities in heart histology and the increase in the cardiotoxicity indices, serum lactate dehydrogenase, and creatine kinase-MB activities, as well as plasma cardiac troponin T and B-natriuretic peptide, induced by cisplatin or γ-radiation."( Cardioprotective effect of zingerone against oxidative stress, inflammation, and apoptosis induced by cisplatin or gamma radiation in rats.
Anees, LM; Ibrahim, DM; Soliman, AF, 2018
)
1.5
"Zingerone-treated diabetic groups exhibited significant reduction in LPO levels and restoration of GSH contents."( Modulatory effect of zingerone against STZ-nicotinamide induced type-2 diabetes mellitus in rats.
Alkarbi, ZA; Alshahrani, S; Anwer, T; Firoz Alam, M; Hassan Najmi, A; Khan, G; Siddiqui, R, 2021
)
1.66
"Zingerone treatment significantly improved behavioral outputs (p<0.05) and histological architecture (p<0.001) by reducing lipid peroxidation (p<0.01), augmenting the reduced glutathione content (p<0.01) and restoring Na(+)-K(+) ATPase and superoxide dismutase activities (p<0.01) in MCAO brain."( Delayed administration of zingerone mitigates the behavioral and histological alteration via repression of oxidative stress and intrinsic programmed cell death in focal transient ischemic rats.
Ahmed, ME; Islam, F; Javed, H; Khan, A; Safhi, MM; Shrivastava, P; Tabassum, R; Vaibhav, K, 2013
)
1.41
"Zingerone treated cells showed increased susceptibility to variety of antibiotics, serum as well as macrophages (p<0.05). "( Structural alterations in Pseudomonas aeruginosa by zingerone contribute to enhanced susceptibility to antibiotics, serum and phagocytes.
Chhibber, S; Harjai, K; Kumar, L, 2014
)
2.1
"Zingerone treatment attenuated CCl4-induced increases in inflammatory mediators, including tumor necrosis factor-α, interleukin-1β, cyclooxygenase-2, and inducible nitric oxide synthase mRNA levels."( Hepatoprotective effects of zingerone on carbon tetrachloride- and dimethylnitrosamine-induced liver injuries in rats.
Bak, J; Cheong, KO; Chung, HY; Je, NK; Kim, KW; Lee, C; Moon, JO; Shin, DS; Yoon, S, 2016
)
1.45
"Zingerone pretreatment significantly (P<0.05) decreased serum cTnI, Hs CRP, lysosomal hydrolases and heart lysosomal LPO and down regulated myocardial TNF-α, IL-1β and IL-6 genes and prevented coronary thrombosis in isoproterenol induced myocardial infarcted rats."( Anti-inflammatory and anti-thrombotic effects of zingerone in a rat model of myocardial infarction.
Hemalatha, KL; Stanely Mainzen Prince, P, 2016
)
1.41
"The treatment with Zingerone attenuated the gain in final body weights, preserved liver structure, and downregulated the transcription of Bax and cleaved caspase-3."( Zingerone ameliorates non-alcoholic fatty liver disease in rats by activating AMPK.
Mohammed, HM, 2022
)
2.48
"The treatment with zingerone markedly abrogated ROS levels, inhibited the NF-кB activation and considerably reduced level of other downstream inflammatory molecules (TNF-α, IL-6, IL-1β), furthermore, zingerone treatment improved renal functioning by significantly decreasing the levels of kidney toxicity markers KIM-1, BUN, creatinine, and LDH and suppressed TGF-β."( Zingerone (4-(4-hydroxy-3-methylphenyl)butan-2-one) ameliorates renal function via controlling oxidative burst and inflammation in experimental diabetic nephropathy.
Ahmad, B; Ahmad, SB; Bhat, SA; Ganaie, MA; Madkhali, H; Majid, S; Rashid, SM; Rasool, S; Rehman, MU; Shakeel, S, 2019
)
2.28
"Treatment with zingerone to DMH treated rats, resulted in alterations in the activity of the cytochrome P450 2E1 and CEA."( Chemopreventive efficacy zingerone (4-[4-hydroxy-3-methylphenyl] butan-2-one) in experimental colon carcinogenesis in Wistar rats.
Al Saeedan, A; Ganaie, MA; Jan, BL; Khatlani, T; Madhkali, H; Rehman, MU; Sheikh, IA; Wani, K, 2019
)
1.16
"Pretreatment with zingerone daily for 14 days revealed significant preventive effects on the electrophoretic and biochemical parameters evaluated in isoproterenol-induced rats."( Preventive effects of zingerone on altered lipid peroxides and nonenzymatic antioxidants in the circulation of isoproterenol-induced myocardial infarcted rats.
Hemalatha, KL; Prince, PS, 2015
)
1.06
"Pretreatment with zingerone (vanillyl acetone) revealed preventive effects on tachycardia, LVH, ECG, and all the above mentioned biochemical parameters evaluated in isoproterenol induced myocardial infarcted rats."( A biochemical and 2, 3, 5-triphenyl tetrazolium chloride staining study on the preventive effects of zingerone (vanillyl acetone) in experimentally induced myocardial infarcted rats.
Hemalatha, KL; Stanely Mainzen Prince, P, 2015
)
0.96
"Pretreatment with zingerone prevented hyperlipidaemia and cardiac hypertrophy, by virtue of its antihyperlipidaemic, antihypertrophic, and reducing properties in isoproterenol-induced myocardial infarcted rats."( Antihyperlipidaemic, antihypertrophic, and reducing effects of zingerone on experimentally induced myocardial infarcted rats.
Hemalatha, KL; Stanely Mainzen Prince, P, 2015
)
0.98

Toxicity

ExcerptReferenceRelevance
" Nephrotoxicity is the most common limiting side effect of cisplatin use."( Protective effects of zingerone on oxidative stress and inflammation in cisplatin-induced rat nephrotoxicity.
Alibakhshi, T; Khodayar, MJ; Khorsandi, L; Rashno, M; Zeidooni, L, 2018
)
0.8
"Among the heavy metal poisonings, lead is considered as a major toxic metal causing hematological, neurological, immunological, hepatic, and renal dysfunctions."( Zingerone prevents lead-induced toxicity in liver and kidney tissues by regulating the oxidative damage in Wistar rats.
Ahmad, P; Ahmad, SB; Amin, I; Arafah, A; Ganaie, SA; Hussain, I; Mir, BA; Mir, MUR; Muzamil, S; Rehman, MU; Shanaz, S, 2021
)
2.06

Bioavailability

This study sought to prepare a self-microemulsion drug delivery system containing zingerone (Z-SMEDDS) to improve the low oral bioavailability of zinger one and anti-tumor effect.

ExcerptReferenceRelevance
"This study sought to prepare a self-microemulsion drug delivery system containing zingerone (Z-SMEDDS) to improve the low oral bioavailability of zingerone and anti-tumor effect."( Improvement of Oral Bioavailability and Anti-Tumor Effect of Zingerone Self-Microemulsion Drug Delivery System.
Adu-Frimpong, M; Bao, R; Cao, X; Wang, QL; Wang, YP; Wei, CM; Weng, W; Xu, XM; Yu, JN; Zhu, Q, 2021
)
1.09
"Herein, a nano-micelle drug delivery system was developed to orally improved zingerone's bioavailability and its antitumor effect."( Improved oral bioavailability, cellular uptake, and cytotoxic activity of zingerone via nano-micelles drug delivery system.
Ge, Z; Wang, Q; Xu, X; Yu, J; Yusif, M; Zhu, Q, 2021
)
1.08

Dosage Studied

Oral or intraperitoneal dosage (100mg/kg) of zingerone resulted in the urinary excretion of most metabolites within 24 h, mainly as glucuronide and/or sulphate conjugates. Lure dosage had a significant effect on the duration of the mating advantage.

ExcerptRelevanceReference
" Oral or intraperitoneal dosage (100mg/kg) of zingerone resulted in the urinary excretion of most metabolites within 24 h, mainly as glucuronide and/or sulphate conjugates."( The metabolism of zingerone, a pungent principle of ginger.
Monge, P; Scheline, R; Solheim, E, 1976
)
0.85
" The mammary carcinogenesis was produced through a single dosage of DMBA (20 mg/kg bwt) mixed in soya oil (1 mL) administrated intragastrically with a gavage."( Zingerone induced caspase-dependent apoptosis in MCF-7 cells and prevents 7,12-dimethylbenz(a)anthracene-induced mammary carcinogenesis in experimental rats.
Gan, H; Mohan, SK; Veeraraghavan, VP; Xie, X; Zhang, Y; Zheng, L; Zhou, Q, 2019
)
1.96
" La performance multifonctionnelle de l’AZ comme agent antioxydant, absorbant et éliminateur a été établie à l’aide de dosages chimiques in vitro standard pour l’industrie, après quoi son efficacité à un dosage plus biologique a été confirmée par sa capacité in vitro à réduire les taux intracellulaires d’espèces réactives de l’oxygène (ROS) dans les kératinocytes exposés au rayonnement UV."( Acetyl zingerone: An efficacious multifunctional ingredient for continued protection against ongoing DNA damage in melanocytes after sun exposure ends.
Brash, D; Chaudhuri, RK; Meyer, T; Premi, S, 2020
)
1.01
" Lure dosage had a significant effect on the duration of the mating advantage, for example when fed 20 µg of zingerone, the advantage lasted only 1 day post-feeding, but when fed of 50 µg zingerone the advantage lasted 7 days."( Male-lure type, lure dosage, and fly age at feeding all influence male mating success in Jarvis' fruit fly.
Clarke, AR; Wee, SL, 2020
)
0.77
" Finally, dosage and safety concerns related to ginger extracts are also documented."( A comprehensive review on Ginger (Zingiber officinale) as a potential source of nutraceuticals for food formulations: Towards the polishing of gingerol and other present biomolecules.
Castro-Muñoz, R; Garza-Cadena, C; Gonzalez-Zermeño, EM; Homma-Dueñas, D; Machorro-García, G; Ortega-Rivera, DM; Plata-Gryl, M, 2023
)
0.91
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (7)

RoleDescription
antioxidantA substance that opposes oxidation or inhibits reactions brought about by dioxygen or peroxides.
anti-inflammatory agentAny compound that has anti-inflammatory effects.
radiation protective agentAny compound that is able to protect normal cells from the damage caused by radiation therapy.
antiemeticA drug used to prevent nausea or vomiting. An antiemetic may act by a wide range of mechanisms: it might affect the medullary control centres (the vomiting centre and the chemoreceptive trigger zone) or affect the peripheral receptors.
flavouring agentA food additive that is used to added improve the taste or odour of a food.
fragranceA substance, extract, or preparation for diffusing or imparting an agreeable or attractive smell.
plant metaboliteAny eukaryotic metabolite produced during a metabolic reaction in plants, the kingdom that include flowering plants, conifers and other gymnosperms.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (3)

ClassDescription
phenolsOrganic aromatic compounds having one or more hydroxy groups attached to a benzene or other arene ring.
monomethoxybenzeneCompounds containing a benzene skeleton substituted with one methoxy group.
methyl ketoneA ketone of formula RC(=O)CH3 (R =/= H).
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (9)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
AR proteinHomo sapiens (human)Potency2.45410.000221.22318,912.5098AID743035
estrogen receptor 2 (ER beta)Homo sapiens (human)Potency24.33650.000657.913322,387.1992AID1259377
nuclear receptor subfamily 1, group I, member 3Homo sapiens (human)Potency61.13060.001022.650876.6163AID1224838; AID1224893
retinoid X nuclear receptor alphaHomo sapiens (human)Potency27.07960.000817.505159.3239AID1159527; AID1159531
estrogen nuclear receptor alphaHomo sapiens (human)Potency32.77060.000229.305416,493.5996AID1259244; AID743069; AID743078
Voltage-dependent calcium channel gamma-2 subunitMus musculus (house mouse)Potency68.58960.001557.789015,848.9004AID1259244
Glutamate receptor 2Rattus norvegicus (Norway rat)Potency68.58960.001551.739315,848.9004AID1259244
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Polyphenol oxidase 2Agaricus bisporusIC50 (µMol)100.00000.03403.987110.0000AID450483
Androgen receptorHomo sapiens (human)IC50 (µMol)152.17800.00000.875310.0000AID473864
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (56)

Processvia Protein(s)Taxonomy
negative regulation of transcription by RNA polymerase IIAndrogen receptorHomo sapiens (human)
MAPK cascadeAndrogen receptorHomo sapiens (human)
in utero embryonic developmentAndrogen receptorHomo sapiens (human)
regulation of systemic arterial blood pressureAndrogen receptorHomo sapiens (human)
epithelial cell morphogenesisAndrogen receptorHomo sapiens (human)
transcription by RNA polymerase IIAndrogen receptorHomo sapiens (human)
signal transductionAndrogen receptorHomo sapiens (human)
G protein-coupled receptor signaling pathwayAndrogen receptorHomo sapiens (human)
cell-cell signalingAndrogen receptorHomo sapiens (human)
spermatogenesisAndrogen receptorHomo sapiens (human)
single fertilizationAndrogen receptorHomo sapiens (human)
positive regulation of cell population proliferationAndrogen receptorHomo sapiens (human)
negative regulation of cell population proliferationAndrogen receptorHomo sapiens (human)
positive regulation of gene expressionAndrogen receptorHomo sapiens (human)
male somatic sex determinationAndrogen receptorHomo sapiens (human)
intracellular estrogen receptor signaling pathwayAndrogen receptorHomo sapiens (human)
androgen receptor signaling pathwayAndrogen receptorHomo sapiens (human)
intracellular receptor signaling pathwayAndrogen receptorHomo sapiens (human)
positive regulation of intracellular estrogen receptor signaling pathwayAndrogen receptorHomo sapiens (human)
Leydig cell differentiationAndrogen receptorHomo sapiens (human)
multicellular organism growthAndrogen receptorHomo sapiens (human)
positive regulation of phosphorylationAndrogen receptorHomo sapiens (human)
positive regulation of MAPK cascadeAndrogen receptorHomo sapiens (human)
positive regulation of insulin-like growth factor receptor signaling pathwayAndrogen receptorHomo sapiens (human)
positive regulation of cell differentiationAndrogen receptorHomo sapiens (human)
negative regulation of integrin biosynthetic processAndrogen receptorHomo sapiens (human)
positive regulation of integrin biosynthetic processAndrogen receptorHomo sapiens (human)
positive regulation of DNA-templated transcriptionAndrogen receptorHomo sapiens (human)
positive regulation of transcription by RNA polymerase IIAndrogen receptorHomo sapiens (human)
positive regulation of transcription by RNA polymerase IIIAndrogen receptorHomo sapiens (human)
insulin-like growth factor receptor signaling pathwayAndrogen receptorHomo sapiens (human)
regulation of developmental growthAndrogen receptorHomo sapiens (human)
animal organ formationAndrogen receptorHomo sapiens (human)
male genitalia morphogenesisAndrogen receptorHomo sapiens (human)
epithelial cell proliferationAndrogen receptorHomo sapiens (human)
negative regulation of epithelial cell proliferationAndrogen receptorHomo sapiens (human)
positive regulation of NF-kappaB transcription factor activityAndrogen receptorHomo sapiens (human)
activation of prostate induction by androgen receptor signaling pathwayAndrogen receptorHomo sapiens (human)
morphogenesis of an epithelial foldAndrogen receptorHomo sapiens (human)
lateral sprouting involved in mammary gland duct morphogenesisAndrogen receptorHomo sapiens (human)
prostate gland growthAndrogen receptorHomo sapiens (human)
prostate gland epithelium morphogenesisAndrogen receptorHomo sapiens (human)
epithelial cell differentiation involved in prostate gland developmentAndrogen receptorHomo sapiens (human)
tertiary branching involved in mammary gland duct morphogenesisAndrogen receptorHomo sapiens (human)
mammary gland alveolus developmentAndrogen receptorHomo sapiens (human)
positive regulation of epithelial cell proliferation involved in prostate gland developmentAndrogen receptorHomo sapiens (human)
cellular response to steroid hormone stimulusAndrogen receptorHomo sapiens (human)
cellular response to estrogen stimulusAndrogen receptorHomo sapiens (human)
cellular response to testosterone stimulusAndrogen receptorHomo sapiens (human)
seminiferous tubule developmentAndrogen receptorHomo sapiens (human)
non-membrane-bounded organelle assemblyAndrogen receptorHomo sapiens (human)
positive regulation of miRNA transcriptionAndrogen receptorHomo sapiens (human)
regulation of protein localization to plasma membraneAndrogen receptorHomo sapiens (human)
negative regulation of extrinsic apoptotic signaling pathwayAndrogen receptorHomo sapiens (human)
male gonad developmentAndrogen receptorHomo sapiens (human)
intracellular steroid hormone receptor signaling pathwayAndrogen receptorHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (23)

Processvia Protein(s)Taxonomy
transcription cis-regulatory region bindingAndrogen receptorHomo sapiens (human)
RNA polymerase II cis-regulatory region sequence-specific DNA bindingAndrogen receptorHomo sapiens (human)
DNA-binding transcription factor activity, RNA polymerase II-specificAndrogen receptorHomo sapiens (human)
RNA polymerase II general transcription initiation factor bindingAndrogen receptorHomo sapiens (human)
transcription coactivator bindingAndrogen receptorHomo sapiens (human)
DNA-binding transcription activator activity, RNA polymerase II-specificAndrogen receptorHomo sapiens (human)
chromatin bindingAndrogen receptorHomo sapiens (human)
DNA-binding transcription factor activityAndrogen receptorHomo sapiens (human)
nuclear receptor activityAndrogen receptorHomo sapiens (human)
G protein-coupled receptor activityAndrogen receptorHomo sapiens (human)
signaling receptor bindingAndrogen receptorHomo sapiens (human)
steroid bindingAndrogen receptorHomo sapiens (human)
androgen bindingAndrogen receptorHomo sapiens (human)
protein bindingAndrogen receptorHomo sapiens (human)
beta-catenin bindingAndrogen receptorHomo sapiens (human)
zinc ion bindingAndrogen receptorHomo sapiens (human)
enzyme bindingAndrogen receptorHomo sapiens (human)
ATPase bindingAndrogen receptorHomo sapiens (human)
molecular adaptor activityAndrogen receptorHomo sapiens (human)
RNA polymerase II-specific DNA-binding transcription factor bindingAndrogen receptorHomo sapiens (human)
POU domain bindingAndrogen receptorHomo sapiens (human)
molecular condensate scaffold activityAndrogen receptorHomo sapiens (human)
estrogen response element bindingAndrogen receptorHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (8)

Processvia Protein(s)Taxonomy
plasma membraneAndrogen receptorHomo sapiens (human)
nucleusAndrogen receptorHomo sapiens (human)
nucleoplasmAndrogen receptorHomo sapiens (human)
cytoplasmAndrogen receptorHomo sapiens (human)
cytosolAndrogen receptorHomo sapiens (human)
nuclear speckAndrogen receptorHomo sapiens (human)
chromatinAndrogen receptorHomo sapiens (human)
protein-containing complexAndrogen receptorHomo sapiens (human)
nucleusAndrogen receptorHomo sapiens (human)
plasma membraneGlutamate receptor 2Rattus norvegicus (Norway rat)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (49)

Assay IDTitleYearJournalArticle
AID1347086qHTS for Inhibitors of the Functional Ribonucleoprotein Complex (vRNP) of Lymphocytic Choriomeningitis Arenaviruses (LCMV): LCMV Primary Screen - GLuc reporter signal2020Antiviral research, 01, Volume: 173A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity.
AID1347083qHTS for Inhibitors of the Functional Ribonucleoprotein Complex (vRNP) of Lassa (LASV) Arenavirus: Viability assay - alamar blue signal for LASV Primary Screen2020Antiviral research, 01, Volume: 173A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity.
AID1347082qHTS for Inhibitors of the Functional Ribonucleoprotein Complex (vRNP) of Lassa (LASV) Arenavirus: LASV Primary Screen - GLuc reporter signal2020Antiviral research, 01, Volume: 173A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity.
AID1427103Inhibition of TGFbeta1-induced invasion in human SNU182 cells at 40 uM measured after 48 hrs in presence of (E)-1-(9-Ethyl-9H-carbazol-3-yl)-5-(4-hydroxy-3-methoxyphenyl)pent-1-en-3-one by microscopic method2017Bioorganic & medicinal chemistry letters, 02-15, Volume: 27, Issue:4
Combined treatment with zingerone and its novel derivative synergistically inhibits TGF-β1 induced epithelial-mesenchymal transition, migration and invasion of human hepatocellular carcinoma cells.
AID1427109Inhibition of TGFbeta1-induced epithelial-mesenchymal transition in human SNU182 cells assessed as reduction in MMP2 mRNA expression preincubated for 2 hrs followed by TGFbeta1 addition measured after 48 hrs in presence of (E)-1-(9-Ethyl-9H-carbazol-3-yl)2017Bioorganic & medicinal chemistry letters, 02-15, Volume: 27, Issue:4
Combined treatment with zingerone and its novel derivative synergistically inhibits TGF-β1 induced epithelial-mesenchymal transition, migration and invasion of human hepatocellular carcinoma cells.
AID450468Inhibition of melanogenesis in theophylline-stimulated mouse B16-4A5 cells at 10 uM after 72 hrs2009Bioorganic & medicinal chemistry, Aug-15, Volume: 17, Issue:16
Melanogenesis inhibitors from the rhizomes of Alpinia officinarum in B16 melanoma cells.
AID450477Inhibition of theophylline-stimulated mouse B16-4A5 cell proliferation assessed as cell viability after 68 hrs by WST8 assay2009Bioorganic & medicinal chemistry, Aug-15, Volume: 17, Issue:16
Melanogenesis inhibitors from the rhizomes of Alpinia officinarum in B16 melanoma cells.
AID450466Inhibition of melanogenesis in theophylline-stimulated mouse B16-4A5 cells at 1 uM after 72 hrs2009Bioorganic & medicinal chemistry, Aug-15, Volume: 17, Issue:16
Melanogenesis inhibitors from the rhizomes of Alpinia officinarum in B16 melanoma cells.
AID1427111Inhibition of TGFbeta1-induced epithelial-mesenchymal transition in human SNU182 cells assessed as reduction in MMP9 mRNA expression preincubated for 2 hrs followed by TGFbeta1 addition measured after 48 hrs in presence of (E)-1-(9-Ethyl-9H-carbazol-3-yl)2017Bioorganic & medicinal chemistry letters, 02-15, Volume: 27, Issue:4
Combined treatment with zingerone and its novel derivative synergistically inhibits TGF-β1 induced epithelial-mesenchymal transition, migration and invasion of human hepatocellular carcinoma cells.
AID1427125Inhibition of TGFbeta1-induced AP-1 binding activity in human SNU182 cells at 20 to 40 uM measured after 48 hrs in presence of (E)-1-(9-Ethyl-9H-carbazol-3-yl)-5-(4-hydroxy-3-methoxyphenyl)pent-1-en-3-one by luciferase reporter gene assay2017Bioorganic & medicinal chemistry letters, 02-15, Volume: 27, Issue:4
Combined treatment with zingerone and its novel derivative synergistically inhibits TGF-β1 induced epithelial-mesenchymal transition, migration and invasion of human hepatocellular carcinoma cells.
AID450480Inhibition of mushroom tyrosinase at 10 uM2009Bioorganic & medicinal chemistry, Aug-15, Volume: 17, Issue:16
Melanogenesis inhibitors from the rhizomes of Alpinia officinarum in B16 melanoma cells.
AID1427079Growth inhibition of human SNU182 cells at <50 uM after 48 hrs by CCK8 assay2017Bioorganic & medicinal chemistry letters, 02-15, Volume: 27, Issue:4
Combined treatment with zingerone and its novel derivative synergistically inhibits TGF-β1 induced epithelial-mesenchymal transition, migration and invasion of human hepatocellular carcinoma cells.
AID473864Antagonist activity at AR in human MDA-kb2 cells co-transfected with MMTV-luc assessed as decrease in DHT-induced luciferase activity by reporter gene assay2010Bioorganic & medicinal chemistry letters, Apr-01, Volume: 20, Issue:7
Effect of essential oils, such as raspberry ketone and its derivatives, on antiandrogenic activity based on in vitro reporter gene assay.
AID450479Inhibition of mushroom tyrosinase at 3 uM2009Bioorganic & medicinal chemistry, Aug-15, Volume: 17, Issue:16
Melanogenesis inhibitors from the rhizomes of Alpinia officinarum in B16 melanoma cells.
AID450472Inhibition of theophylline-stimulated mouse B16-4A5 cell proliferation assessed as cell viability at 1 uM after 68 hrs by WST8 assay2009Bioorganic & medicinal chemistry, Aug-15, Volume: 17, Issue:16
Melanogenesis inhibitors from the rhizomes of Alpinia officinarum in B16 melanoma cells.
AID1427121Inhibition of TGFbeta1-induced p44/42 MAPK phosphorylation in human SNU182 cells measured after 48 hrs in presence of (E)-1-(9-Ethyl-9H-carbazol-3-yl)-5-(4-hydroxy-3-methoxyphenyl)pent-1-en-3-one by Western blot method2017Bioorganic & medicinal chemistry letters, 02-15, Volume: 27, Issue:4
Combined treatment with zingerone and its novel derivative synergistically inhibits TGF-β1 induced epithelial-mesenchymal transition, migration and invasion of human hepatocellular carcinoma cells.
AID1427101Inhibition of TGFbeta1-induced migration in human SNU182 cells at 40 uM measured after 48 hrs in presence of (E)-1-(9-Ethyl-9H-carbazol-3-yl)-5-(4-hydroxy-3-methoxyphenyl)pent-1-en-3-one by wound healing assay2017Bioorganic & medicinal chemistry letters, 02-15, Volume: 27, Issue:4
Combined treatment with zingerone and its novel derivative synergistically inhibits TGF-β1 induced epithelial-mesenchymal transition, migration and invasion of human hepatocellular carcinoma cells.
AID450470Inhibition of melanogenesis in theophylline-stimulated mouse B16-4A5 cells at 100 uM after 72 hrs2009Bioorganic & medicinal chemistry, Aug-15, Volume: 17, Issue:16
Melanogenesis inhibitors from the rhizomes of Alpinia officinarum in B16 melanoma cells.
AID1427095Inhibition of TGFbeta1-induced epithelial-mesenchymal transition in human SNU182 cells assessed as reduction in mesenchymal phenotype preincubated for 2 hrs followed by TGFbeta1 addition measured after 48 hrs in presence of (E)-1-(9-Ethyl-9H-carbazol-3-yl2017Bioorganic & medicinal chemistry letters, 02-15, Volume: 27, Issue:4
Combined treatment with zingerone and its novel derivative synergistically inhibits TGF-β1 induced epithelial-mesenchymal transition, migration and invasion of human hepatocellular carcinoma cells.
AID1427093Inhibition of TGFbeta1-induced epithelial-mesenchymal transition in human SNU182 cells assessed as reduction in upregulation of Snail expression preincubated for 2 hrs followed by TGFbeta1 addition measured after 48 hrs in presence of (E)-1-(9-Ethyl-9H-ca2017Bioorganic & medicinal chemistry letters, 02-15, Volume: 27, Issue:4
Combined treatment with zingerone and its novel derivative synergistically inhibits TGF-β1 induced epithelial-mesenchymal transition, migration and invasion of human hepatocellular carcinoma cells.
AID1427082Growth inhibition of human SNU182 cells at <50 uM in presence of (E)-1-(9-Ethyl-9H-carbazol-3-yl)-5-(4-hydroxy-3-methoxyphenyl)pent-1-en-3-one after 48 hrs by CCK8 assay2017Bioorganic & medicinal chemistry letters, 02-15, Volume: 27, Issue:4
Combined treatment with zingerone and its novel derivative synergistically inhibits TGF-β1 induced epithelial-mesenchymal transition, migration and invasion of human hepatocellular carcinoma cells.
AID450475Inhibition of theophylline-stimulated mouse B16-4A5 cell proliferation assessed as cell viability at 30 uM after 68 hrs by WST8 assay2009Bioorganic & medicinal chemistry, Aug-15, Volume: 17, Issue:16
Melanogenesis inhibitors from the rhizomes of Alpinia officinarum in B16 melanoma cells.
AID1427097Inhibition of TGFbeta1-induced epithelial-mesenchymal transition in human SNU182 cells assessed as reduction in upregulation of N-cadherin expression preincubated for 2 hrs followed by TGFbeta1 addition measured after 48 hrs in presence of (E)-1-(9-Ethyl-2017Bioorganic & medicinal chemistry letters, 02-15, Volume: 27, Issue:4
Combined treatment with zingerone and its novel derivative synergistically inhibits TGF-β1 induced epithelial-mesenchymal transition, migration and invasion of human hepatocellular carcinoma cells.
AID1427117Inhibition of TGFbeta1-induced IkB-alpha phosphorylation in human SNU182 cells at 20 to 40 uM preincubated for 2 hrs followed by TGFbeta1 addition measured after 120 mins in presence of (E)-1-(9-Ethyl-9H-carbazol-3-yl)-5-(4-hydroxy-3-methoxyphenyl)pent-1-2017Bioorganic & medicinal chemistry letters, 02-15, Volume: 27, Issue:4
Combined treatment with zingerone and its novel derivative synergistically inhibits TGF-β1 induced epithelial-mesenchymal transition, migration and invasion of human hepatocellular carcinoma cells.
AID450473Inhibition of theophylline-stimulated mouse B16-4A5 cell proliferation assessed as cell viability at 3 uM after 68 hrs by WST8 assay2009Bioorganic & medicinal chemistry, Aug-15, Volume: 17, Issue:16
Melanogenesis inhibitors from the rhizomes of Alpinia officinarum in B16 melanoma cells.
AID450478Inhibition of mushroom tyrosinase at 1 uM2009Bioorganic & medicinal chemistry, Aug-15, Volume: 17, Issue:16
Melanogenesis inhibitors from the rhizomes of Alpinia officinarum in B16 melanoma cells.
AID473865Agonist activity at AR in human MDA-kb2 cells co-transfected with MMTV-luc assessed as increase in DHT-induced luciferase activity at 1 mM by reporter gene assay2010Bioorganic & medicinal chemistry letters, Apr-01, Volume: 20, Issue:7
Effect of essential oils, such as raspberry ketone and its derivatives, on antiandrogenic activity based on in vitro reporter gene assay.
AID91529Effective dose to protect IMR-32 cells from beta-Amyloid (BA) insult was determined using MTT reduction assay2004Bioorganic & medicinal chemistry letters, Mar-08, Volume: 14, Issue:5
Side-chain length is important for shogaols in protecting neuronal cells from beta-amyloid insult.
AID1427113Inhibition of TGFbeta1-induced epithelial-mesenchymal transition in human SNU182 cells assessed as reduction in MMP9 activity measured after 48 hrs in presence of (E)-1-(9-Ethyl-9H-carbazol-3-yl)-5-(4-hydroxy-3-methoxyphenyl)pent-1-en-3-one by gelatin zym2017Bioorganic & medicinal chemistry letters, 02-15, Volume: 27, Issue:4
Combined treatment with zingerone and its novel derivative synergistically inhibits TGF-β1 induced epithelial-mesenchymal transition, migration and invasion of human hepatocellular carcinoma cells.
AID450469Inhibition of melanogenesis in theophylline-stimulated mouse B16-4A5 cells at 30 uM after 72 hrs2009Bioorganic & medicinal chemistry, Aug-15, Volume: 17, Issue:16
Melanogenesis inhibitors from the rhizomes of Alpinia officinarum in B16 melanoma cells.
AID450471Inhibition of melanogenesis in theophylline-stimulated mouse B16-4A5 cells after 72 hrs2009Bioorganic & medicinal chemistry, Aug-15, Volume: 17, Issue:16
Melanogenesis inhibitors from the rhizomes of Alpinia officinarum in B16 melanoma cells.
AID1427091Inhibition of TGFbeta1-induced epithelial-mesenchymal transition in human SNU182 cells assessed as reduction in downregulation of E-cadherin expression preincubated for 2 hrs followed by TGFbeta1 addition measured after 48 hrs in presence of (E)-1-(9-Ethy2017Bioorganic & medicinal chemistry letters, 02-15, Volume: 27, Issue:4
Combined treatment with zingerone and its novel derivative synergistically inhibits TGF-β1 induced epithelial-mesenchymal transition, migration and invasion of human hepatocellular carcinoma cells.
AID450483Inhibition of mushroom tyrosinase2009Bioorganic & medicinal chemistry, Aug-15, Volume: 17, Issue:16
Melanogenesis inhibitors from the rhizomes of Alpinia officinarum in B16 melanoma cells.
AID156507Effective dose to protect PC12 cells from beta-Amyloid (BA) insult was determined using MTT reduction assay2004Bioorganic & medicinal chemistry letters, Mar-08, Volume: 14, Issue:5
Side-chain length is important for shogaols in protecting neuronal cells from beta-amyloid insult.
AID697852Inhibition of electric eel AChE at 2 mg/ml by Ellman's method2012Bioorganic & medicinal chemistry, Nov-15, Volume: 20, Issue:22
Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.
AID697853Inhibition of horse BChE at 2 mg/ml by Ellman's method2012Bioorganic & medicinal chemistry, Nov-15, Volume: 20, Issue:22
Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.
AID1427087Inhibition of TGFbeta1-induced epithelial-mesenchymal transition in human SNU182 cells assessed as reduction in downregulation of E-cadherin expression at 40 uM preincubated for 2 hrs followed by TGFbeta1 addition measured after 48 hrs by Western blot met2017Bioorganic & medicinal chemistry letters, 02-15, Volume: 27, Issue:4
Combined treatment with zingerone and its novel derivative synergistically inhibits TGF-β1 induced epithelial-mesenchymal transition, migration and invasion of human hepatocellular carcinoma cells.
AID1427099Inhibition of TGFbeta1-induced SMAD2 phosphorylation in human SNU182 cells at 20 to 40 uM preincubated for 2 hrs followed by TGFbeta1 addition measured after 48 hrs in presence of (E)-1-(9-Ethyl-9H-carbazol-3-yl)-5-(4-hydroxy-3-methoxyphenyl)pent-1-en-3-o2017Bioorganic & medicinal chemistry letters, 02-15, Volume: 27, Issue:4
Combined treatment with zingerone and its novel derivative synergistically inhibits TGF-β1 induced epithelial-mesenchymal transition, migration and invasion of human hepatocellular carcinoma cells.
AID450476Inhibition of theophylline-stimulated mouse B16-4A5 cell proliferation assessed as cell viability at 100 uM after 68 hrs by WST8 assay2009Bioorganic & medicinal chemistry, Aug-15, Volume: 17, Issue:16
Melanogenesis inhibitors from the rhizomes of Alpinia officinarum in B16 melanoma cells.
AID450467Inhibition of melanogenesis in theophylline-stimulated mouse B16-4A5 cells at 3 uM after 72 hrs2009Bioorganic & medicinal chemistry, Aug-15, Volume: 17, Issue:16
Melanogenesis inhibitors from the rhizomes of Alpinia officinarum in B16 melanoma cells.
AID450482Inhibition of mushroom tyrosinase at 100 uM2009Bioorganic & medicinal chemistry, Aug-15, Volume: 17, Issue:16
Melanogenesis inhibitors from the rhizomes of Alpinia officinarum in B16 melanoma cells.
AID1427105Inhibition of TGFbeta1-induced epithelial-mesenchymal transition in human SNU182 cells assessed as reduction in MMP2 mRNA expression at 40 uM preincubated for 2 hrs followed by TGFbeta1 addition measured after 48 hrs by qRT-PCR method2017Bioorganic & medicinal chemistry letters, 02-15, Volume: 27, Issue:4
Combined treatment with zingerone and its novel derivative synergistically inhibits TGF-β1 induced epithelial-mesenchymal transition, migration and invasion of human hepatocellular carcinoma cells.
AID450481Inhibition of mushroom tyrosinase at 30 uM2009Bioorganic & medicinal chemistry, Aug-15, Volume: 17, Issue:16
Melanogenesis inhibitors from the rhizomes of Alpinia officinarum in B16 melanoma cells.
AID1427089Inhibition of TGFbeta1-induced epithelial-mesenchymal transition in human SNU182 cells assessed as reduction in upregulation of Snail expression at 40 uM preincubated for 2 hrs followed by TGFbeta1 addition measured after 48 hrs by Western blot method2017Bioorganic & medicinal chemistry letters, 02-15, Volume: 27, Issue:4
Combined treatment with zingerone and its novel derivative synergistically inhibits TGF-β1 induced epithelial-mesenchymal transition, migration and invasion of human hepatocellular carcinoma cells.
AID1427107Inhibition of TGFbeta1-induced epithelial-mesenchymal transition in human SNU182 cells assessed as reduction in MMP9 mRNA expression at 40 uM preincubated for 2 hrs followed by TGFbeta1 addition measured after 48 hrs by qRT-PCR method2017Bioorganic & medicinal chemistry letters, 02-15, Volume: 27, Issue:4
Combined treatment with zingerone and its novel derivative synergistically inhibits TGF-β1 induced epithelial-mesenchymal transition, migration and invasion of human hepatocellular carcinoma cells.
AID1427115Inhibition of TGFbeta1-induced epithelial-mesenchymal transition in human SNU182 cells assessed as reduction in MMP2 activity measured after 48 hrs in presence of (E)-1-(9-Ethyl-9H-carbazol-3-yl)-5-(4-hydroxy-3-methoxyphenyl)pent-1-en-3-one by gelatin zym2017Bioorganic & medicinal chemistry letters, 02-15, Volume: 27, Issue:4
Combined treatment with zingerone and its novel derivative synergistically inhibits TGF-β1 induced epithelial-mesenchymal transition, migration and invasion of human hepatocellular carcinoma cells.
AID1427123Inhibition of TGFbeta1-induced NF-kB binding activity in human SNU182 cells at 20 to 40 uM measured after 48 hrs in presence of (E)-1-(9-Ethyl-9H-carbazol-3-yl)-5-(4-hydroxy-3-methoxyphenyl)pent-1-en-3-one by luciferase reporter gene assay2017Bioorganic & medicinal chemistry letters, 02-15, Volume: 27, Issue:4
Combined treatment with zingerone and its novel derivative synergistically inhibits TGF-β1 induced epithelial-mesenchymal transition, migration and invasion of human hepatocellular carcinoma cells.
AID450474Inhibition of theophylline-stimulated mouse B16-4A5 cell proliferation assessed as cell viability at 10 uM after 68 hrs by WST8 assay2009Bioorganic & medicinal chemistry, Aug-15, Volume: 17, Issue:16
Melanogenesis inhibitors from the rhizomes of Alpinia officinarum in B16 melanoma cells.
AID1427119Inhibition of TGFbeta1-induced NF-kB nuclear translocation in human SNU182 cells preincubated for 2 hrs followed by TGFbeta1 addition measured after 12 hrs in presence of (E)-1-(9-Ethyl-9H-carbazol-3-yl)-5-(4-hydroxy-3-methoxyphenyl)pent-1-en-3-one by Wes2017Bioorganic & medicinal chemistry letters, 02-15, Volume: 27, Issue:4
Combined treatment with zingerone and its novel derivative synergistically inhibits TGF-β1 induced epithelial-mesenchymal transition, migration and invasion of human hepatocellular carcinoma cells.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (178)

TimeframeStudies, This Drug (%)All Drugs %
pre-19907 (3.93)18.7374
1990's10 (5.62)18.2507
2000's18 (10.11)29.6817
2010's85 (47.75)24.3611
2020's58 (32.58)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 45.20

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index45.20 (24.57)
Research Supply Index5.23 (2.92)
Research Growth Index5.33 (4.65)
Search Engine Demand Index68.12 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (45.20)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials3 (1.65%)5.53%
Reviews8 (4.40%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other171 (93.96%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]